NCT07542977

Brief Summary

The goal of this observational study is to evaluate intra-individual neurophysiological variability in children and adults with and without NeuroDevelopmental Disorders (NDD), for several sensory modalities and types of stimulation. The main hypotheses are:

  • NDD participants and children exhibit higher intra-individual variability than other participants
  • intra-individual neurophysiological variability is correlated to behavioral, psychological and learning profiles Participants in this study will:
  • be recorded for EEG and other neurophysiological parameters while exposed to sensory stimulations, to quantify sensory neurophysiological variability
  • perform behavioral tests and fill out questionnaires, to establish the behavioral and psychological profile
  • train for perceptual learning, to measure learning abilities These evaluations will be split in 3 visits spread on a maximum of 3 months, and training for learning will be done at home in between 2 visits.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
23mo left

Started Apr 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Apr 2026Apr 2028

First Submitted

Initial submission to the registry

March 26, 2026

Completed
20 days until next milestone

Study Start

First participant enrolled

April 15, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 21, 2026

Completed
24 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2026

Expected
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2028

Last Updated

April 21, 2026

Status Verified

April 1, 2026

Enrollment Period

1 month

First QC Date

March 26, 2026

Last Update Submit

April 17, 2026

Conditions

Keywords

SensoryNeurophysiologyProfile

Outcome Measures

Primary Outcomes (3)

  • Amplitude of central neurophysiological responses to sensory stimulations

    Amplitude (in micro-volts) of event-related potentials

    Through study completion, an average of 2 months per participant

  • Latency of central neurophysiological responses to sensory stimulations

    Latency (in milli-seconds) of event-related potentials

    Through study completion, an average of 2 months per participant

  • Variability of central neurophysiological responses to sensory stimulations

    Intra-individual variability (in percentage) of event-related potentials

    Through study completion, an average of 2 months per participant

Secondary Outcomes (12)

  • Visual perceptual learning performance

    Through study completion, an average of 2 months per participant

  • Auditory perceptual learning performance

    Through study completion, an average of 2 months per participant

  • Behavioral sensory profile

    Through study completion, an average of 2 months per participant

  • Sensory profile questionnaire

    Through study completion, an average of 2 months per participant

  • Cognitive psychological profile

    Through study completion, an average of 2 months per participant

  • +7 more secondary outcomes

Study Arms (4)

Neurodevelopmental Disorders Children

6-12 years old children

Neurodevelopmental Disorders Adults

18-45 years old adults

Neurotypical Children

6-12 years old children

Neurotypical Adults

18-45 years old adults

Eligibility Criteria

Age6 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Participants will be adults between 18 and 45 years old and children between 6 and 12 years old, with or without a Neurodevelopmental Disorder.

You may qualify if:

  • Social security affiliation
  • Free and written informed consent from the participants (Neurotypical Adults, NDD Adults without judicial protective measures), or their tutor or legal representant(s) (other participants)
  • Age between 6 and 12 years included (Children) or between 18 and 45 years included (Adults)
  • For NDD participants: NDD diagnosis by a qualified medical professional, according to DSM-4, DSM-5, ICD-10 or ICD-11 criteria
  • Psychotropic medication perturbing EEG recording
  • Drugs pertubing peripheral neurophysiological measures
  • Non-corrected visual or auditory troubles
  • Epilepsy
  • For Neurotypical participants: NDD diagnosis
  • For NDD participants: anticipated psychological or physical risk at participating, at the investigator's discretion

You may not qualify if:

  • Participants with no data to evaluate Outcome 1

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Neurodevelopmental Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 26, 2026

First Posted

April 21, 2026

Study Start

April 15, 2026

Primary Completion (Estimated)

May 15, 2026

Study Completion (Estimated)

April 15, 2028

Last Updated

April 21, 2026

Record last verified: 2026-04